At the time of writing, Hims & Hers Health Inc [HIMS] stock is trading at $40040000.0, up 42237080%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HIMS shares have gain 12.37% over the last week, with a monthly amount glided 4.92%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 04, 2025, when Needham reiterated its Buy rating and also boosted its price target to $65 from $61. Previously, TD Cowen downgraded its rating to Hold on April 29, 2025, and kept the price target unchanged to $30. On February 18, 2025, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $60 on the stock. Citigroup downgraded its rating to a Sell and increased its price target to $25 on January 10, 2025. BTIG Research initiated its recommendation with a Buy and recommended $35 as its price target on January 07, 2025. Morgan Stanley started tracking with a Overweight rating for this stock on December 17, 2024, and assigned it a price target of $42. In a note dated November 14, 2024, BofA Securities downgraded an Underperform rating on this stock.
For the past year, the stock price of Hims & Hers Health Inc fluctuated between $13.47 and $72.98. Currently, Wall Street analysts expect the stock to reach $66.5 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $40040000.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
According to Hims & Hers Health Inc [NYSE:HIMS], the company’s sales were 1.78B for trailing twelve months, which represents an 110.67% jump. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.36 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Hims & Hers Health Inc [NYSE:HIMS] has a current ratio of 1.59. In addition, the Quick Ratio stands at 1.32 and the Cash Ratio stands at 0.98. Considering the valuation of this stock, the price to sales ratio is 8.06, the price to book ratio is 26.14 and price to earnings (TTM) ratio is 93.48.
Transactions by insiders
Recent insider trading involved Chi Michael, Chief Commercial Officer, that happened on Jun 17 ’25 when 17102.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Jun 16 ’25 to sell 0.13 million shares. Meanwhile, Chief Executive Officer Dudum Andrew sold 65110.0 shares on Jun 17 ’25.
